Emtricitabin/Tenofovirdisoproxil Amarox 200 mg/245 mg film-coated tablets
Treatment of HIV-1 infection: Emtricitabin/Tenofovirdisoproxil Amarox is indicated in antiretroviral combination therapy for the treatment of HIV-1 infected adults (see section 5.1). Emtricitabin/Tenofovirdisoproxil Amarox is also indicated for the treatment of HIV-1 infected adolescents, with NRTI resistance or toxicities precluding the use of first line agents (see sections 4.2, 4.4 and 5.1). Pre-exposure prophylaxis (PrEP): Emtricitabin/Tenofovirdisoproxil Amarox is indicated in combination with safer sex practices for pre-exposure prophylaxis to reduce the risk of sexually acquired HIV-1 infection in adults and adolescents at high risk (see sections 4.2, 4.4 and 5.1).